-
2
-
-
0037137299
-
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
-
DOI 10.1161/01.CIR.0000038493.65177.94
-
Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil,omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-2757. (Pubitemid 35364932)
-
(2002)
Circulation
, vol.106
, Issue.21
, pp. 2747-2757
-
-
Kris-Etherton, P.M.1
Harris, W.S.2
Appel, L.J.3
-
3
-
-
0024363690
-
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART)
-
Burr ML, Fehily AM, Gilbert JF. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761. (Pubitemid 19234807)
-
(1989)
Lancet
, vol.2
, Issue.8666
, pp. 757-761
-
-
Burr, M.L.1
Fehily, A.M.2
Gilbert, J.F.3
Rogers, S.4
Holliday, R.M.5
Sweetnam, P.M.6
Elwood, P.C.7
Deadman, N.M.8
-
4
-
-
0345109256
-
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: Results of the GISSI-Prevenzione trial
-
Valagussa F, Franzosi MG, Geraci E, et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
-
(1999)
Lancet
, vol.354
, pp. 447-455
-
-
Valagussa, F.1
Franzosi, M.G.2
Geraci, E.3
-
5
-
-
70349731956
-
Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects
-
Roth EM, Bays HE, Forker AD, et al. Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects. J Cardiovasc Pharmacol. 2009;54(3):196-203.
-
(2009)
J Cardiovasc Pharmacol
, vol.54
, Issue.3
, pp. 196-203
-
-
Roth, E.M.1
Bays, H.E.2
Forker, A.D.3
-
6
-
-
75749115919
-
Effects of prescription omega-3-acid ethyl esters on non-high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin
-
Bays HE, McKenney J, Maki KC, et al. Effects of prescription omega-3-acid ethyl esters on non-high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. Mayo Clin Proc. 2010;85(2):122-128.
-
(2010)
Mayo Clin Proc
, vol.85
, Issue.2
, pp. 122-128
-
-
Bays, H.E.1
McKenney, J.2
Maki, K.C.3
-
7
-
-
77949511855
-
Long term up to 24 month efficacy and safety of concomitant prescription omega-3 acid ethyl esters and simvastatin in hypertriglyceridemic patients
-
Bays HE, Maki KC, McKenney J, et al. Long term up to 24 month efficacy and safety of concomitant prescription omega-3 acid ethyl esters and simvastatin in hypertriglyceridemic patients. Curr Med Res Opin. 2010;26(4):907-915.
-
(2010)
Curr Med Res Opin
, vol.26
, Issue.4
, pp. 907-915
-
-
Bays, H.E.1
Maki, K.C.2
McKenney, J.3
-
8
-
-
77950555307
-
Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after PCI to modify responsiveness to dual antiplatelet therapy) study
-
Gajos G, Rostoff P, Undas A, et al. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after PCI to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol. 2010;55:1671-1678.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1671-1678
-
-
Gajos, G.1
Rostoff, P.2
Undas, A.3
-
9
-
-
53049110571
-
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial
-
GISSI-HF Investigators
-
GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1223-1230.
-
(2008)
Lancet
, vol.372
, pp. 1223-1230
-
-
-
10
-
-
74949090172
-
Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure
-
Zhao YT, Teng LL, Luo Y, et al. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. J Int Med Res. 2009;37:1831-1841.
-
(2009)
J Int Med Res
, vol.37
, pp. 1831-1841
-
-
Zhao, Y.T.1
Teng, L.L.2
Luo, Y.3
-
11
-
-
79953722922
-
Natriuretic peptide system and cardiovascular disease
-
Federico C. Natriuretic peptide system and cardiovascular disease. Heart Views. 2010;11(1):10-15.
-
(2010)
Heart Views
, vol.11
, Issue.1
, pp. 10-15
-
-
Federico, C.1
-
12
-
-
77749264445
-
Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus
-
Stirban A, Nandrean S, Götting C, et al. Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr. 2010;91:808-813.
-
(2010)
Am J Clin Nutr
, vol.91
, pp. 808-813
-
-
Stirban, A.1
Nandrean, S.2
Götting, C.3
-
13
-
-
67549136395
-
Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoetins, and adinopectin in patients with type II diabetes mellitus
-
Nomura S, Shouzu A, Omoto S, et al. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoetins, and adinopectin in patients with type II diabetes mellitus. J Atheroscler Thromb. 2009;16(2):83-90.
-
(2009)
J Atheroscler Thromb
, vol.16
, Issue.2
, pp. 83-90
-
-
Nomura, S.1
Shouzu, A.2
Omoto, S.3
-
14
-
-
77956474516
-
Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery
-
Mariscalco G, Sarzi Braga S, Banach M, et al. Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery. Angiology. 2010;61(7):643-650.
-
(2010)
Angiology
, vol.61
, Issue.7
, pp. 643-650
-
-
Mariscalco, G.1
Sarzi Braga, S.2
Banach, M.3
-
15
-
-
77649330535
-
Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial
-
Saravanan P, Bridgewater B, West AL, et al. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol. 2010;3(1):46-53.
-
(2010)
Circ Arrhythm Electrophysiol
, vol.3
, Issue.1
, pp. 46-53
-
-
Saravanan, P.1
Bridgewater, B.2
West, A.L.3
-
16
-
-
70349566488
-
Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A prospective randomized study
-
Heidt MC, Vician M, Stracke SK, et al. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg. 2009;57(5):276-280.
-
(2009)
Thorac Cardiovasc Surg
, vol.57
, Issue.5
, pp. 276-280
-
-
Heidt, M.C.1
Vician, M.2
Stracke, S.K.3
|